| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00432208 |
| P8608 | Fatcat ID | release_ljrymignl5gavlao3zfl5lqw6e |
| P698 | PubMed publication ID | 2863836 |
| P50 | author | Carl-Gerhard Gottfries | Q16632987 |
| P2860 | cites work | Some Cerebral Proteins and Enzyme Systems in Alzheimer's Presenile and Senile Dementia | Q34160060 |
| Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain | Q34714755 | ||
| Vasopressin and memory consolidation | Q39220300 | ||
| Neocortical cholinergic neurons in elderly people | Q39428914 | ||
| Accelerated ageing or selective neuronal loss as an important cause of dementia? | Q39525178 | ||
| Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa | Q40083223 | ||
| A critique of the vasopressin-memory hypothesis | Q40213479 | ||
| Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. | Q41472935 | ||
| Neurochemical characteristics of early and late onset types of Alzheimer's disease | Q43051550 | ||
| Vasopressin in amnesia | Q43624439 | ||
| Microchemical pathology of the cerebral cortex in pre-senile dementias | Q44552583 | ||
| Necropsy evidence of central cholinergic deficits in senile dementia | Q48319379 | ||
| Selective loss of central cholinergic neurons in Alzheimer's disease | Q48342983 | ||
| Brain-decarboxylase activities as indices of pathological change in senile dementia | Q48547472 | ||
| Human memory and the cholinergic system. A relationship to aging? | Q48584703 | ||
| Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer-Type Dementia | Q48641408 | ||
| Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). | Q48849823 | ||
| The Investigation of Homovanillic Acid in the Human Brain and its Correlation to Senile Dementia | Q49028545 | ||
| Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. | Q50869517 | ||
| INFLUENCE OF ANTERIOR PITUITARY ON AVOIDANCE LEARNING AND ESCAPE BEHAVIOR. | Q51273163 | ||
| Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid related to rated mental and motor impairment in senile and presenile dementia | Q51331278 | ||
| Tryptophan malabsorption in dementia. Improvement in certain cases after tryptophan therapy as indicated by mental behaviour and blood analysis | Q52101237 | ||
| Changes in the brain catecholamines in patients with dementia of Alzheimer type. | Q53178323 | ||
| Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. | Q53307980 | ||
| Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. | Q53307999 | ||
| Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide. | Q53310418 | ||
| Limbic lobe involvement in presenile dementia | Q66892206 | ||
| Dementia, deep white matter damage and hypertension: 'Binswanger's disease' | Q70707484 | ||
| Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type | Q71337143 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| Alzheimer's disease | Q11081 | ||
| senile dementia | Q11610626 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 245-252 | |
| P577 | publication date | 1985-01-01 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment | |
| P478 | volume | 86 |
| Q51376437 | A proteomics study reveals a predominant change in MaoB expression in platelets of healthy volunteers after high protein meat diet: relationship to the methylation cycle. |
| Q48120495 | Age as risk factor for sporadic dementia of the Alzheimer type? |
| Q48863675 | Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats |
| Q52197305 | Ameliorating effects of SDZ ENA 713 on age-associated decreases in learning performance and brain choline acetyltransferase activity in rats. |
| Q57074728 | Chapter 4. Cognitive Disorders |
| Q52135420 | Cognitive effects of L-deprenyl in Alzheimer's disease. |
| Q52057907 | Cognitive effects of milacemide and methylphenidate in healthy young adults. |
| Q39173624 | Critical review of clinical trials in senile dementia--II. |
| Q28285775 | Depression and senile dementia of the Alzheimer type: a role for moclobemide |
| Q69449361 | Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors? |
| Q36179666 | Donepezil (E2020): a new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer's disease |
| Q48263154 | Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease |
| Q45342938 | Effects of combined serotonin depletion and lesions of the nucleus basalis magnocellularis on acquisition of a complex spatial discrimination task in the rat |
| Q72567161 | Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice |
| Q67602112 | Effects of nefiracetam, a novel pyrrolidone derivative, on brain monoamine metabolisms in mice |
| Q52123094 | Enhanced passive avoidance retention following posttrain serotonergic receptor antagonist administration in middle-aged and aged rats. |
| Q48172445 | Evidence for homeostatic adjustments of rat somatosensory cortical neurons to changes in extracellular acetylcholine concentrations produced by iontophoretic administration of acetylcholine and by systemic diisopropylfluorophosphate treatment |
| Q48302893 | Increased activity of surviving locus ceruleus neurons in Alzheimer's disease |
| Q53191486 | Intravenous nicotine in Alzheimer's disease: a pilot study. |
| Q56457062 | MKC-231, a choline uptake enhancer, ameliorates working memory deficits and decreased hippocampal acetylcholine induced by ethylcholine aziridinium ion in mice |
| Q48681712 | Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease |
| Q37679725 | Memory-Enhancing Effects of the Crude Extract of Polygala tenuifolia on Aged Mice |
| Q39581676 | Molecular biology and neurobiology of choline acetyltransferase |
| Q53217287 | Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type. |
| Q34407516 | Pharmacology of the neurotransmitter release enhancer linopirdine (DuP 996), and insights into its mechanism of action |
| Q69727957 | Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normal level |
| Q37195343 | Platelets: A possible glance into brain biological processes in schizophrenia |
| Q37726596 | Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy |
| Q46298132 | Relationship between saliva level of 3-methoxy-4-hydroxyphenylglycol and mental health in the elderly general population |
| Q67870191 | Reversal effect of DM-9384 on scopolamine-induced acetylcholine depletion in certain regions of the mouse brain |
| Q42207513 | Reversal of scopolamine-induced amnesia of passive avoidance by pre- and post-training naloxone |
| Q42210723 | Scopolamine amnesia of passive avoidance: a deficit of information acquisition |
| Q41317848 | Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease |
| Q41163764 | Senile dementia: a threshold phenomenon of normal aging? A contribution to the functional reserve hypothesis of the brain |
| Q39756011 | The cholinergic neurotransmitter system in human memory and dementia: a review |
| Q28266471 | The new generation of monoamine oxidase inhibitors |
| Q41950395 | Unrecognized dementia: sociodemographic correlates |
Search more.